3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with mercaptopurine in 2 studies
| Studies (3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione) | Trials (3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione) | Recent Studies (post-2010) (3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione) | Studies (mercaptopurine) | Trials (mercaptopurine) | Recent Studies (post-2010) (mercaptopurine) |
|---|---|---|---|---|---|
| 49 | 7 | 8 | 6,554 | 445 | 1,198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hutchison, DJ; Schmid, FA; Stock, CC; Tarnowski, GS | 1 |
2 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and mercaptopurine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Ascites; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Drug Resistance; Leukemia L1210; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines; Piperidines; Transplantation, Homologous | 1973 |